PeterRossing HerlevDenmark

Peter Rossing graduated as a MD from the University of Copenhagen Medical School in 1991. After graduating he joined the Steno Diabetes Center as a research fellow 1991-96. After submitting his DMSc. thesis "Promotion, prediction and prevention of progression in diabetic nephropathy" defended in 1998, he entered his clinical training at the University of Copenhagen Hospitals, to obtain a specialist degree in internal medicine and endocrinology 2004. Since 2007 he has been a chief physician and manager of the Steno Diabetes Center research team dedicated to the research of micro-and macrovascular complications of diabetes, and from 2010-14 and 2016- Head of Research at SDC. Since 2012 Professor in diabetic angiopathy at University of Copenhagen. Peter Rossing has in epidemiological studies investigated key features of the pathophysiology of the diabetic kidney at different stages. He has identified several markers for development of diabetic nephropathy, making it possible to predict the individual risk He demonstrated that a reduction in urinary albumin excretion after onset of antihypertensive therapy in diabetic nephropathy was the best predictor of a successful treatment outcome. He has been involved in several intervention studies in patients with overt diabetic nephropathy aiming at improving the prognosis. Coordinator of the EU FP7 project PRIORITY and the NNF Challenge grant PROTON. Received the Minkowski prize from the EASD in 2005, Ruth Østerby award in 2013 and Golgi award 2016. Past president of the Danish Endocrine Society, current president of the European Diabetic Nephropathy Study group and chairman of the Danish National Diabetes Registry.